On the contrary, cholesterol-lowering drugs or genetic variants could impair glucose homeostasis and lead to diabetes by decreasing pancreatic β-cell insulin secretion or inducing insulin resistance of skeletal muscle cells, adipocytes, or hepatocytes. Here, INS is linked to diabetes mellitus.